Spin-off of the University of Verona and the University of Milan specialized in regenerative medicine for neurological diseases. After years of studies and research conducted by its founding scientists, Hemera is born to develop a revolutionary cellular therapy for the regeneration of damaged nerve tissues, which finds its first application in the treatment of acute spinal cord injuries.
Company Details
- Employees
- 13
- Founded
- -
- Address
- Verona, Verona,vr 37122,italy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://hemerapharma.com/
- Keywords
- Regenerative Medicine, Cell Therapy, Orphan Disease, Orphan Drug, Advanced Therapy, Central Nervous System Disorders, Regeneration of Damaged Nervous Tissue, Spinal Cord Injury, Acute Neurological Trauma.
- HQ
- Verona, VR
Hemera Pharma Questions
Hemera Pharma's website is https://hemerapharma.com/
Hemera Pharma's LinkedIn profile is https://it.linkedin.com/company/hemera-pharma
Hemera Pharma has
13 employees.
View email and phone details for 13
employees at Hemera Pharma.
Hemera Pharma's industry is
Biotechnology Research
Hemera Pharma's top competitors are
Gammadonna,
Fondazione Iu Rusconi Ghigi,
Holostem S.r.l.,
Genespire,
Vib,
Genenta Science (Nasdaq: Gnta),
Bti Biotechnology Institute,
Talea Consulting,
Alba Robot,
Stem Ems.
Hemera Pharma's categories are Biotechnology Research
Hemera Pharma's founding year is 2021
